Palvella Therapeutics, Inc. (PVLA)
100.35
-4.32
(-4.13%)
USD |
NASDAQ |
Jan 02, 16:00
100.35
0.00 (0.00%)
After-Hours: 17:14
Palvella Therapeutics Total Assets (Quarterly): 66.94M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 233.89M |
| Ligand Pharmaceuticals, Inc. | 1.477B |
| Pelthos Therapeutics, Inc. | 126.43M |
| Inhibrx Biosciences, Inc. | 177.47M |
| CEL-SCI Corp. | 28.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.26M |
| Shareholders Equity (Quarterly) | 38.68M |
| Debt to Equity Ratio | 0.4142 |
| Current Ratio | 6.491 |
| Net Debt Paydown Yield | -0.46% |